ISZO CAPITAL MANAGEMENT LP - Q2 2023 holdings

$18.2 Million is the total value of ISZO CAPITAL MANAGEMENT LP's 3 reported holdings in Q2 2023. The portfolio turnover from Q1 2023 to Q2 2023 was 114.3% .

 Value Shares↓ Weighting
CO ExitGLOBAL CORD BLOOD CORPORATIO$0-279,495
-100.0%
0.00%
FRC ExitFIRST REP BK SAN FRANCISCO C$0-52,000
-100.0%
-3.87%
SPY ExitSPDR S&P 500 ETF TRtr unit$0-2,500
-100.0%
-5.44%
NVO ExitNOVO-NORDISK A Sadr$0-7,000
-100.0%
-5.92%
QQQ ExitINVESCO QQQ TRunit ser 1$0-4,800
-100.0%
-8.19%
UTHR ExitUNITED THERAPEUTICS CORP DEL$0-9,000
-100.0%
-10.72%
NVS ExitNOVARTIS AGsponsored adr$0-22,000
-100.0%
-10.76%
ExitCBL & ASSOC PPTYS INC$0-82,081
-100.0%
-11.19%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NAM TAI PPTY INC16Q3 202260.5%
AVID BIOSERVICES INC13Q4 202146.6%
XPEL INC10Q4 202122.3%
TARO PHARMACEUTICALS INDUS LTD8Q4 201585.7%
AMERCO8Q4 201511.2%
NATHANS FAMOUS INC NEW7Q1 201768.9%
MMA CAP MGMT LLC7Q1 201717.8%
CBL & ASSOC PPTYS INC6Q3 202395.2%
LIFECORE BIOMEDICAL INC6Q4 202235.1%
CRYO-CELL INTL INC6Q4 202211.0%

View ISZO CAPITAL MANAGEMENT LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-12

View ISZO CAPITAL MANAGEMENT LP's complete filings history.

Compare quarters

Export ISZO CAPITAL MANAGEMENT LP's holdings